Erlotinib Impurity 16 | CAS 1241475-15-9 - Request Quote
Erlotinib Impurity 16
| SZ CAT No: | SZ-E018033 |
| CAS No | 1241475-15-9 |
| Mol.F. | C16H25N3O5 |
| Mol.Wt. | 339.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Erlotinib Impurity 16 is chemically (E)-2-(((dimethylamino)methylene)amino)-4,5-bis(2-methoxyethoxy)benzamide. Erlotinib Impurity 16 is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib Impurity 16 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1241475-15-9
Purchase 1241475-15-9
Order 1241475-15-9
Enquire 1241475-15-9
price of 1241475-15-9
1241475-15-9 Supplier
1241475-15-9 Manufacturer
1241475-15-9 Exporter
buy high quality Erlotinib Impurity 16
Purchase Erlotinib Impurity 16
Erlotinib Impurity 16 suppliers
Erlotinib Impurity 16 manufacturers
Erlotinib Impurity 16 price
Order Erlotinib Impurity 16
Enquire Erlotinib Impurity 16
Erlotinib Impurity 16 cost
Erlotinib Impurity 16 Supplier
Erlotinib Impurity 16 Distributor
Erlotinib Impurity 16 for Method Validation
Erlotinib Reference Standard
Erlotinib Impurity 16 for ANDA Filing
Erlotinib Impurity 16 for Forced Degradation Studies
Erlotinib Impurity 16 Identification Standards
Erlotinib Impurity 16 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.